secwatch.observer — SEC 8-K summary
======================================

Issuer:     LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK:        0001062822
Form:       8-K
Filed at:   2025-01-07T23:59:59+00:00
Accession:  0001062822-25-000005
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Lexicon Pharmaceuticals receives Nasdaq bid-price deficiency notice; 180 days to cure
--------------------------------------------------------------------------------

- Nasdaq notified Lexicon on Jan 3, 2025 that bid price closed below $1 for 31 consecutive business days.
- Company has until July 2, 2025 to regain compliance by closing at $1+ for 10 consecutive days.
- If not cured, Lexicon may seek a second 180-day period if it meets other listing standards; reverse split considered.
- Notice does not cause immediate delisting; company will monitor and evaluate options.
- No assurance that compliance can be regained or maintained.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1062822/000106282225000005/0001062822-25-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1062822/000106282225000005/lxrx-20250103.htm
  HTML page:      https://secwatch.observer/filing/0001062822-25-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer